Have you ever heard any of these acronyms, and wondered what they stand for and how they can affect your treatment plan? This webinar is designed to help patients better understand biomarkers, and how these biomarkers can affect the treatment options patients receive.
We’ll discuss the basic understandings of a cancer cell lives, and how it dies. As researchers are learning more and more about how to treat colorectal cancer, it is bringing the meaning of truly personalized medicine to the forefront.
Join us to learn more, and how this research may affect your overall treatment plan.
Associate Professor, Department of Gastrointestinal (GI) Medical OncologyDr. Cathy Eng is Associate Professor in the Department of Gastrointestinal (GI) Medical Oncology at The University of Texas M. D. Anderson Cancer Center. Dr. Eng received her medical degree from Hahnemann University School of Medicine in Philadelphia, PA, followed by an internship and residency at Rush-Presbyterian St. Luke’s Medical Center in Chicago, IL. She went on to complete a fellowship in Hematology/Oncology at University of Chicago Medical Center. Dr. Eng is board certified in internal medicine and medical oncology.
Watch a recording of the webinar: